Borderline resectable pancreatic cancer
Surgery followed by adjuvant chemotherapy remains the only treatment option for pancreatic ductal adenocarcinoma (PDAC) with the chance of long-term survival. If a radical tumor resection is possible, 5-year survival rates of 20-25% can be achieved. Pancreatic surgery has significantly changed durin...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
23 February 2016
|
| In: |
Cancer letters
Year: 2016, Jahrgang: 375, Heft: 2, Pages: 231-237 |
| ISSN: | 1872-7980 |
| DOI: | 10.1016/j.canlet.2016.02.039 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.canlet.2016.02.039 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0304383516301070 |
| Verfasserangaben: | Thilo Hackert, Alexis Ulrich, Markus W. Büchler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1728821274 | ||
| 003 | DE-627 | ||
| 005 | 20220818191159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200903s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canlet.2016.02.039 |2 doi | |
| 035 | |a (DE-627)1728821274 | ||
| 035 | |a (DE-599)KXP1728821274 | ||
| 035 | |a (OCoLC)1341358570 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hackert, Thilo |d 1971- |e VerfasserIn |0 (DE-588)122158512 |0 (DE-627)70579346X |0 (DE-576)182659208 |4 aut | |
| 245 | 1 | 0 | |a Borderline resectable pancreatic cancer |c Thilo Hackert, Alexis Ulrich, Markus W. Büchler |
| 264 | 1 | |c 23 February 2016 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.09.2020 | ||
| 520 | |a Surgery followed by adjuvant chemotherapy remains the only treatment option for pancreatic ductal adenocarcinoma (PDAC) with the chance of long-term survival. If a radical tumor resection is possible, 5-year survival rates of 20-25% can be achieved. Pancreatic surgery has significantly changed during the past years and resection approaches have been extended beyond standard procedures, including vascular and multivisceral resections. Consequently, borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC), which has recently been defined by the International Study Group for Pancreatic Surgery (ISGPS), has become a controversial issue with regard to its management in terms of upfront resection vs. neoadjuvant treatment and sequential resection. Preoperative diagnostic accuracy to define resectability of PDAC is a keypoint in this context as well as the surgical and interdisciplinary expertise to perform advanced pancreatic surgery and manage complications. The present mini-review summarizes the current state of definition, management and outcome of BR-PDAC. Furthermore, the topic of ongoing and future studies on neoadjuvant treatment which is closely related to borderline resectability in PDAC is discussed. | ||
| 650 | 4 | |a Borderline resectable | |
| 650 | 4 | |a Pancreatic cancer | |
| 650 | 4 | |a Therapy | |
| 700 | 1 | |a Ulrich, Alexis |e VerfasserIn |0 (DE-588)1022952226 |0 (DE-627)717337847 |0 (DE-576)177315083 |4 aut | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer letters |d Amsterdam [u.a.] : Elsevier Science, 1975 |g 375(2016), 2, Seite 231-237 |h Online-Ressource |w (DE-627)320434796 |w (DE-600)2004212-7 |w (DE-576)261677926 |x 1872-7980 |7 nnas |a Borderline resectable pancreatic cancer |
| 773 | 1 | 8 | |g volume:375 |g year:2016 |g number:2 |g pages:231-237 |g extent:7 |a Borderline resectable pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.canlet.2016.02.039 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0304383516301070 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200903 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 3 |y j | ||
| 998 | |g 1022952226 |a Ulrich, Alexis |m 1022952226:Ulrich, Alexis |d 910000 |d 910200 |e 910000PU1022952226 |e 910200PU1022952226 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 998 | |g 122158512 |a Hackert, Thilo |m 122158512:Hackert, Thilo |d 910000 |d 910200 |e 910000PH122158512 |e 910200PH122158512 |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1728821274 |e 3746312647 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"23 February 2016"}],"id":{"eki":["1728821274"],"doi":["10.1016/j.canlet.2016.02.039"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"disp":"Borderline resectable pancreatic cancerCancer letters","pubHistory":["1.1975 -"],"recId":"320434796","note":["Gesehen am 22.01.2020"],"id":{"eki":["320434796"],"zdb":["2004212-7"],"issn":["1872-7980"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedDisp":"1975-","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1975","publisher":"Elsevier Science"}],"part":{"extent":"7","year":"2016","issue":"2","volume":"375","text":"375(2016), 2, Seite 231-237","pages":"231-237"},"title":[{"title":"Cancer letters","subtitle":"an international journal providing a forum for original and pertinent contributions in cancer research","title_sort":"Cancer letters"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"7 S."}],"person":[{"role":"aut","family":"Hackert","display":"Hackert, Thilo","given":"Thilo"},{"display":"Ulrich, Alexis","family":"Ulrich","given":"Alexis","role":"aut"},{"role":"aut","family":"Büchler","display":"Büchler, Markus W.","given":"Markus W."}],"title":[{"title":"Borderline resectable pancreatic cancer","title_sort":"Borderline resectable pancreatic cancer"}],"note":["Gesehen am 03.09.2020"],"recId":"1728821274","name":{"displayForm":["Thilo Hackert, Alexis Ulrich, Markus W. Büchler"]}} | ||
| SRT | |a HACKERTTHIBORDERLINE2320 | ||